DE69019148T2 - D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. - Google Patents

D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.

Info

Publication number
DE69019148T2
DE69019148T2 DE69019148T DE69019148T DE69019148T2 DE 69019148 T2 DE69019148 T2 DE 69019148T2 DE 69019148 T DE69019148 T DE 69019148T DE 69019148 T DE69019148 T DE 69019148T DE 69019148 T2 DE69019148 T2 DE 69019148T2
Authority
DE
Germany
Prior art keywords
hydroxamate
tumors
viral infections
treating viral
acid beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69019148T
Other languages
English (en)
Other versions
DE69019148D1 (de
Inventor
Jorge Vila
Nicole Thomasset
Sangsari Farid Hamedi
Jacques Grange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of DE69019148D1 publication Critical patent/DE69019148D1/de
Application granted granted Critical
Publication of DE69019148T2 publication Critical patent/DE69019148T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69019148T 1989-04-28 1990-04-27 D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren. Expired - Fee Related DE69019148T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8905744A FR2646348A1 (fr) 1989-04-28 1989-04-28 D-aspartique acide-hydroxamate en tant que medicament
PCT/FR1990/000307 WO1990013291A1 (fr) 1989-04-28 1990-04-27 D-acide aspartique beta-hydroxamate pour le traitement des infections virales et des tumeurs

Publications (2)

Publication Number Publication Date
DE69019148D1 DE69019148D1 (de) 1995-06-08
DE69019148T2 true DE69019148T2 (de) 1995-08-31

Family

ID=9381297

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69019148T Expired - Fee Related DE69019148T2 (de) 1989-04-28 1990-04-27 D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.

Country Status (11)

Country Link
EP (1) EP0470144B1 (de)
JP (1) JPH04506796A (de)
AT (1) ATE121935T1 (de)
AU (1) AU660916B2 (de)
CA (1) CA2050936A1 (de)
DE (1) DE69019148T2 (de)
DK (1) DK0470144T3 (de)
ES (1) ES2072431T3 (de)
FR (1) FR2646348A1 (de)
OA (1) OA09519A (de)
WO (1) WO1990013291A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705522A (en) * 1995-09-15 1998-01-06 Compagnie De Developpement Aguettant S.A. Compounds having anti-inflammatory and anti-viral activity, compositions of these, alone and in combination with reverse transcriptase inhibitors
BR112012006979A2 (pt) * 2009-09-29 2016-04-05 Shiseido Co Ltd composição antioxidante

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (fr) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus

Also Published As

Publication number Publication date
EP0470144A1 (de) 1992-02-12
OA09519A (fr) 1992-11-15
AU5657590A (en) 1990-11-29
DE69019148D1 (de) 1995-06-08
ATE121935T1 (de) 1995-05-15
AU660916B2 (en) 1995-07-13
CA2050936A1 (fr) 1990-10-29
DK0470144T3 (da) 1995-10-02
JPH04506796A (ja) 1992-11-26
ES2072431T3 (es) 1995-07-16
FR2646348A1 (fr) 1990-11-02
FR2646348B1 (de) 1994-04-22
EP0470144B1 (de) 1995-05-03
WO1990013291A1 (fr) 1990-11-15

Similar Documents

Publication Publication Date Title
DE3850026D1 (de) Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren.
DE3876125T2 (de) Behandlung der menschlichen viralinfektion durch doppelstrang-rna, kombiniert mit viralen inhibitoren.
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
DE59209704D1 (de) 2-Aminomethyl-chromane als Wirkstoffe in Arzneimitteln zur Behandlung von Erkrankungen des Zentralnervensystems
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
DE3882775T2 (de) Zusammensetzung zur Behandlung von parodontaler Krankheit.
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
DK312688D0 (da) Glykkopeptid-antibiotika
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
DE3782214T2 (de) Mittel zur behandlung des scheidenmilieus.
DE3687097T2 (de) Therapeutisches mittel zur behandlung haematopoietischer krankheiten.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
DE69019148D1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE3874606D1 (de) Behandlung von viraler infektion.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
MX9700113A (es) Amido-quinoxalindionas novedosas, su preparacion y uso.
MD515C2 (ro) Procedeu de prelucrare a seminţelor înainte de semănat
FR2665016B1 (fr) Aimants permanents pour le traitement magnetique des plantes ou analogues.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee